HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Noushin Farnoud Selected Research
Noushin Farnoud Research Topics
Disease
5
Neoplasms (Cancer)
01/2022 - 01/2018
4
Primary Myelofibrosis (Myelosclerosis)
01/2023 - 01/2018
4
Polycythemia Vera
12/2022 - 01/2019
3
Blast Crisis (Blast Phase)
01/2022 - 10/2020
3
Leukemia
01/2022 - 10/2016
2
Essential Thrombocythemia
12/2022 - 10/2019
2
Myeloproliferative Disorders (Myeloproliferative Disorder)
10/2019 - 01/2019
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022
1
Fibrosis (Cirrhosis)
08/2019
1
Splenomegaly
08/2019
1
Disease Resistance
01/2018
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2016
1
Intellectual Disability (Idiocy)
09/2006
Drug/Important Bio-Agent (IBA)
3
Cytokines
IBA
01/2023 - 01/2018
3
ruxolitinib
IBA
10/2020 - 01/2019
2
Interferons
IBA
12/2022 - 10/2019
2
Hydroxyurea (Hydrea)
FDA Link
Generic
12/2022 - 10/2019
2
RG7388
IBA
11/2020 - 01/2019
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2021
1
Topoisomerase II Inhibitors
IBA
11/2020
1
Platinum
IBA
11/2020
1
Decitabine
FDA Link
10/2020
1
peginterferon alfa-2a (Pegasys)
FDA Link
10/2019
1
Aurora Kinase A
IBA
08/2019
1
MLN 8237
IBA
08/2019
1
enasidenib
IBA
01/2018
1
Janus Kinase Inhibitors
IBA
01/2018
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
10/2016
1
Proteins (Proteins, Gene)
FDA Link
10/2016
1
Chromatin
IBA
10/2016
1
Oligonucleotides
IBA
09/2006
Therapy/Procedure
8
Therapeutics
12/2022 - 01/2018
1
Induction Chemotherapy
01/2022
1
Transplantation
01/2019
1
Cell Transplantation
01/2019